Table 4.
Associations between the various factors and the risk of having metabolic syndrome
| Variable | OR | 95%CI | p |
|---|---|---|---|
| < 30 years of age | 1.000 | Reference | – |
| 30–49 years of age | 2.149 | 1.122–4.177 | 0.021 |
| ≥50 years of age | 8.587 | 4.087–18.044 | < 0.001 |
| BMI ≥25 kg/m2 | 3.005 | 1.767–5.110 | < 0.001 |
| Antipsychoticsa | 3.595 | 1.722–7.497 | 0.001 |
| Mood stabilizerb | 2.397 | 1.087–5.285 | 0.030 |
| Hyperuricemiac | 3.029 | 1.685–5.443 | < 0.001 |
a: use of antipsychotic drug at clinical dose, b: use of mood stabilizer at clinical dose, c: serum uric acid > 420 μmol/l for men and > 360 μmol/l for women [21]